The popularity of Viagra initially fueled a period of growth for major pharmaceutical companies, however recent shifts present a complicated picture for investors. Off-patent versions are reducing revenue, and https://frasernkmh374533.bluxeblog.com/73591698/sildenafil-and-pharma-a-risky-play